Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07790861 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems

Name: A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems — clinical trial record (NCT07790861)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ATTAIN-CN

StatusNot Yet Recruiting

PhasePhase 3

SponsorEli Lilly and Company

Started2026-12

View on ClinicalTrials.gov ↗

The purpose of this study is to learn how well orforglipron works and how safe it is in Chinese adults with obesity or overweight and related health problems. Participation in this study will last about 53 weeks (about 1 year).

Trial Details

NCT Number	NCT07790861
Lead Sponsor	Eli Lilly and Company
Conditions	Obesity, Overweight
Enrollment	192 participants
Start Date	2026-12
Primary Completion	2028-03 (estimated)
Study Completion	2028-03 (estimated)
Updated on ClinicalTrials.gov	2026-08-27